Freeline Reports December 2022 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Plugin JSON Content Importer Pro not running: Check Licence! Check that a Licence is active for https://freeline.life
You might also like
Freeline Announces May 2022 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Freeline to Present New Data on its Gaucher and Parkinson’s Disease Programs at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting
Freeline Presents Long-Term Follow-Up Data from Phase 1/2 B-AMAZE Trial in Hemophilia B at the 2021 ASH Annual Meeting and Announces Early Initiation of Phase 1/2 B-LIEVE Dose-Confirmation Trial
Freeline announces supply agreement for haemophilia B program
Freeline Initiates Dosing of Second Cohort in MARVEL-1 Trial of FLT190 Gene Therapy Candidate for People with Fabry Disease
Freeline Reports October 2022 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Get in touch

+44 (0)1438 906870
contact@freeline.life

Follow us on our social channels